Abstract

A rapid, simple, and reliable method for the simultaneous estimation of D and O-MD in plasma and brain is described. These compounds are eluted together, but separately from the catecholamines, by passing perchloric acid extracts through columns of a strong cation-exchange resin in the H + form. The pH of the eluate is adjusted with the addition of a Na 3 citrate solution. Specific oxidation of D and O-MD are carried out by reacting with iodine and ferricyanide, respectively. No interference with plasma D and O-MD measurements was found from the presence in plasma of drugs commonly used in the treatment of parkinsonism. The presence of hydrazinomethyldopa and α-methyldopa partially interferes with the determinations of D and O-MD. Plasma levels of O-MD are greater than D in patients receiving chronic l-dopa therapy.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.